West Bengal Chemical Industry Limited, a cGMP, ISO certified one of world’s major manufacturer based in Kolkata, India reigning in API and Neutraceutical industry for over half a century with its unique and uncompromising business vision. Mostly into manufacture of different mineral salts with organic acids and carbohydrates, WBCIL is reckoned to be one of the market leaders in this field.
The product portfolio includes inter alia Iron, Calcium, Magnesium, Potassium, Zinc, Copper, Manganese & Chromium salts with Ascorbate, Acetate, Propionate, Phosphate, Citrate, Aspartate, Gluconate, Bislglycinate, Malate and several other anions which are produced at quality levels stipulated by pharmacopoeias, regulatory food guidelines or customer’s specifications after adaptation of chemical and physical parameters like bulk density, particle size, purity, pH-value, etc. backed with a strong research and development team who are working vigorously on latest available molecules like Iron Isomaltoside, Ferric Carboxymaltose, Ferric Derisomaltose, Ferric Citrate, Ferric Pyrophosphate Citrate, Ferric Maltol, Liposomal Iron, Sucroferric Oxyhydroxide, etc. to keep up with the progressive & advance world market.
We have special expertise in Injectable Grade, DC Grade, Premix, Pellets, LR Grade.
Iron Polymaltose Complex / Ferric Ammonium Citrate / Ferrous Ascorbate / Ferrous Bisglycinate / Ferrous Glycine Sulphate / Ferric Pyrophosphate / Ferrous Asparto Glycinate / Ferric Carboxymaltose / Iron Isomaltoside / Ferric Citrate / Ferric Maltol / Calcium Acetate / Calcium Citrate / Calcium Citrate Malate / Calcium Lactate Gluconate / Calcium Bisglycinate / L – Methylfolate / Sodium Butyrate / Nicorandil / Enclomiphene Citrate are few of our offerings which has gained the confidence of domestic & international customers.
We have also started offering organics molecules like Telmisartan, Dimethyl Fumarate, Meclizine HCL, Aripiprazole, Lamotrigine, Risperidone, Ropivacaine & many others & are increasing our product basket with rapid strides.
